Richard Stead

Acting Chief Medical Officer
Molecular Biology
ISA Pharmaceuticals
Netherlands

Business Expert Molecular Biology
Biography

 Richard Stead has more than 25 years experience in the biotechnology and pharmaceutical industry designing and directing clinical trials, as well as preclinical research and development with companies such as Amgen and Immunex. As Principal of BioPharma Consulting Services since 2002, he has been actively involved in the development of a number oncology products including different strategies for cancer immunotherapy. He also serves an independent director on the Boards of Affimed Therapeutics AG and Ascend Biopharmaceuticals.  

Research Intrest

 Immunotherapy, Biotechnology